The XEGAFRI brand, founded in 2014 (United States), from
2 sister brands
and 2214 competing brands.
XEGAFRI is owned by Clovis Oncology, listed on the stock exchange of Francfort
XEGAFRI is part of the Biotechnology activity sector.
XEGAFRI is a brand of Clovis Oncology (C6O) Share price
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.